NCT04021160

Brief Summary

Visual field defects (VFD) usually do not show improvement beyond 12 weeks from onset. Plasticity occurs in areas of residual vision (ARV) at the visual field which are the functional counterpart of partially damaged brain regions at the areas around brain lesion. Few treatment options are currently available for post-stroke VFD. In this pilot study, the effect of repetitive transcranial magnetic stimulation (rTMS) applied to these areas on VFD in patients with cortical infarction will be studied. Patients will be divided into two groups; an active group which will receive active stimulation and a sham group which will receive placebo stimulation through a sham coil.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
32

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jun 2018

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2018

Completed
10 months until next milestone

First Submitted

Initial submission to the registry

April 6, 2019

Completed
3 months until next milestone

First Posted

Study publicly available on registry

July 16, 2019

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2020

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 5, 2020

Completed
Last Updated

July 21, 2021

Status Verified

July 1, 2021

Enrollment Period

1.8 years

First QC Date

April 6, 2019

Last Update Submit

July 19, 2021

Conditions

Keywords

Transcranial Magnetic Stimulation

Outcome Measures

Primary Outcomes (1)

  • Change in Mean Deviation (MD) of Automated Perimetry

    Change in mean deviation (MD) from baseline will be assessed using automated perimetry's full threshold 30-2 visual field test.

    6 weeks

Secondary Outcomes (2)

  • Change in Visual Field Index (VFI) of Automated Perimetry

    6 weeks

  • National Eye Institute Visual Functioning Questionnaire-25 (VFQ-25)

    6 weeks

Study Arms (2)

Active Group

ACTIVE COMPARATOR

A total of 16, every other day sessions of rTMS at 10 Hz frequency will be applied to 4 locations along the perilesional area (see target selection). Intensity will be 100% of motor threshold, 25 trains - 40 pulses per train with 20 seconds intertrain interval and a total of 1000 pulses per session. The coil handle will be directed downwards at 45º of the sagittal plain to ensure that the induced electric field be perpendicular to the underlying gyrus.

Device: High frequency repetitive transcranial magnetic stimulation (rTMS)

Sham Group

SHAM COMPARATOR

Sham group will receive the same sessions as above with the exact same parameters yet a sham coil identical in shape and size to the active coil will be used instead. The sham coil produces sounds and sensations very similar to the active one.

Device: Sham stimulation

Interventions

10hz, 20 seconds intertrain interval, 40 pulses per train with a total of 1000 pulse per session given at 100% of motor threshold. A total of 16 sessions will be given to each patient.

Active Group

A sham coil will be used that is shielded so that it produces sounds and sensations similar to the active coil but does not produce therapeutic effects. 10hz, 20 seconds intertrain interval, 40 pulses per train with a total of 1000 pulse per session given at 100% of motor threshold. A total of 16 sessions will be given to each patient.

Sham Group

Eligibility Criteria

Age18 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients with a brain imaging showing vascular lesion involving visual cortical area
  • Duration of at least 3 months.

You may not qualify if:

  • Visual field defects of ophthalmologic origin
  • Causes of severe visual impairment other than visual field defects
  • Drug abuse
  • Past history or family history of epilepsy
  • Skull bone defects
  • Implanted metallic devices

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Neuromodulation Research Lab, Neurology Department, Ain Shams University Hospital

Cairo, 11591, Egypt

Location

Related Publications (10)

  • Sabel BA, Henrich-Noack P, Fedorov A, Gall C. Vision restoration after brain and retina damage: the "residual vision activation theory". Prog Brain Res. 2011;192:199-262. doi: 10.1016/B978-0-444-53355-5.00013-0.

    PMID: 21763527BACKGROUND
  • Rossini PM, Barker AT, Berardelli A, Caramia MD, Caruso G, Cracco RQ, Dimitrijevic MR, Hallett M, Katayama Y, Lucking CH, et al. Non-invasive electrical and magnetic stimulation of the brain, spinal cord and roots: basic principles and procedures for routine clinical application. Report of an IFCN committee. Electroencephalogr Clin Neurophysiol. 1994 Aug;91(2):79-92. doi: 10.1016/0013-4694(94)90029-9. No abstract available.

    PMID: 7519144BACKGROUND
  • Pambakian AL, Kennard C. Can visual function be restored in patients with homonymous hemianopia? Br J Ophthalmol. 1997 Apr;81(4):324-8. doi: 10.1136/bjo.81.4.324. No abstract available.

    PMID: 9215064BACKGROUND
  • Rowe F, Brand D, Jackson CA, Price A, Walker L, Harrison S, Eccleston C, Scott C, Akerman N, Dodridge C, Howard C, Shipman T, Sperring U, MacDiarmid S, Freeman C. Visual impairment following stroke: do stroke patients require vision assessment? Age Ageing. 2009 Mar;38(2):188-93. doi: 10.1093/ageing/afn230. Epub 2008 Nov 21.

    PMID: 19029069BACKGROUND
  • Townend BS, Sturm JW, Petsoglou C, O'Leary B, Whyte S, Crimmins D. Perimetric homonymous visual field loss post-stroke. J Clin Neurosci. 2007 Aug;14(8):754-6. doi: 10.1016/j.jocn.2006.02.022. Epub 2007 Jan 30.

    PMID: 17270447BACKGROUND
  • Barker WH, Mullooly JP. Stroke in a defined elderly population, 1967-1985. A less lethal and disabling but no less common disease. Stroke. 1997 Feb;28(2):284-90. doi: 10.1161/01.str.28.2.284.

    PMID: 9040676BACKGROUND
  • Ali M, Hazelton C, Lyden P, Pollock A, Brady M; VISTA Collaboration. Recovery from poststroke visual impairment: evidence from a clinical trials resource. Neurorehabil Neural Repair. 2013 Feb;27(2):133-41. doi: 10.1177/1545968312454683. Epub 2012 Sep 6.

    PMID: 22961263BACKGROUND
  • Janssen AM, Oostendorp TF, Stegeman DF. The coil orientation dependency of the electric field induced by TMS for M1 and other brain areas. J Neuroeng Rehabil. 2015 May 17;12:47. doi: 10.1186/s12984-015-0036-2.

    PMID: 25981522BACKGROUND
  • Perez C, Chokron S. Rehabilitation of homonymous hemianopia: insight into blindsight. Front Integr Neurosci. 2014 Oct 22;8:82. doi: 10.3389/fnint.2014.00082. eCollection 2014.

    PMID: 25374515BACKGROUND
  • Urbanski M, Coubard OA, Bourlon C. Visualizing the blind brain: brain imaging of visual field defects from early recovery to rehabilitation techniques. Front Integr Neurosci. 2014 Sep 30;8:74. doi: 10.3389/fnint.2014.00074. eCollection 2014.

    PMID: 25324739BACKGROUND

MeSH Terms

Conditions

HemianopsiaIschemic StrokeHemorrhagic Stroke

Condition Hierarchy (Ancestors)

Vision DisordersSensation DisordersNeurologic ManifestationsNervous System DiseasesBlindnessEye DiseasesSigns and SymptomsPathological Conditions, Signs and SymptomsStrokeCerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesVascular DiseasesCardiovascular Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

April 6, 2019

First Posted

July 16, 2019

Study Start

June 1, 2018

Primary Completion

April 1, 2020

Study Completion

June 5, 2020

Last Updated

July 21, 2021

Record last verified: 2021-07

Data Sharing

IPD Sharing
Will share
Shared Documents
STUDY PROTOCOL, SAP, ICF

Locations